Sechenov University scientists took part in creation of cancer nanotechnology

26 September 2018

GMP News

Scientists of Sechenov University took part in creation of cancer nanotechnology enables targeted delivery of substantial payloads of drugs to cancer sites with concomitant reduction of side effects due to the lesser accumulation in the critical organs.

This prompts loading of nanocarriers with therapeutic cargo and contrast agents, allowing combined cancer therapy and tumor visualization, respectively. The resultant hybrid complex showed high therapeutic efficiency and high imaging contrast both in vitro and in vivo.

The scientific results were published in the Proceedings of the National Academy of Sciences (PNAS).

Source

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more